Aalto-Korte K, Turpeinen M. Transepidermal water loss and absorption of hydrocortisone in widespread dermatitis. British Journal of Dermatology 1993;128:633-5.
American Conference of Governmental Industrial Hygienists. Threshold limit values for chemical substances and physical agents and biological exposure indices. ACGIH, Cincinnati, Ohio, USA;1999.
Angerer J, Lichterbeck E, Begerow J, Jekel S, Lehnert G. Occupational chronic exposure to organic solvents. XIII. Glycolether exposure during the production of varnishes. Int Arch Occup Environ Health 1990;62:123-6.
Angerer J. Goen T. Kramer A. Kafferlein HU. N-methylcarbamoyl adducts at the N-terminal valine of globin in workers exposed to N,N-dimethylformamide. Arch Toxicol. 1998;72:309-13.
Bortsevich S V. The problem of the hygienic importance of dimethylformamide absorption through the skin. Gig Tr Prof Zabol 1984; 11:55-57.
Chivers CP. Disulfiram effect from inhalation of dimethylformamide. Lancet. (8059):331, 1978
Cox NH, Mustchin CP. Prolonged spontaneous and alcohol-induced flushing due to the solvent dimethylformamide. Contact Dermatitis 1991;24:69-70.
Gascher, A. Dimethylformamide. In Ethel Browning’s Toxicity and Metabolism of Industrial Solvents(Buhler, D. R., and Reed, D. J., Eds) Vol. 2, pp 149-159, Elsevier, Amsterdam.
Kafferlein HU, Angerer J. Simultaneous determination of two human urinary metabolites of N,N-dimethylformamide using gas chromatography-thermionic sensitive detection with mass spectrometric confirmation. J Chromatogr B. 1999;734:285-98.
Kafferlein HU, Goen T, Muller J, Wrbitzky R, Angerer J. Biological monitoring of workers exposed to N,N-dimethylformamide in the synthetic fibre industry. Int Arch Occup Environ Health. 2000;73:113-20.
Kimmerle G, Eben A. Metabolism studies of N,N-dimethylformamide. I. Studies in rats and dogs. Int Arch Arbeitsmed. 1975;34:109-26.
Kimmerle G. Eben A. Metabolism studies of N,N-dimethylformamide. II. Studies in persons. Int Arch Arbeitsmed. 1975;34:127-36.
Lareo AC. Perbellini L. Biological monitoring of workers exposed to N-N-dimethylformamide. II. Dimethylformamide and its metabolites in urine of exposed workers. Int Arch Occup Environ Health. 1995;67:47-52.
Lauwerys R R et. Al. Biological surveillance of workers exposed to dimethylformamide and the influence of skin protection on its percutaneous absorption. Int Arch Occup Environ Health 1980; 45: 189-203.
Lyle WH. Spence TW. McKinneley WM. Duckers K. Dimethylformamide and alcohol intolerance. Bri J Ind Med. 1979;36:63-6.
Mraz J, Galova E, Nohova H, Bouskova S. N-methylcarbamoyl adduct with N-terminal valine of globin: a view biomarker of exposure to N,N-dimethylformamide (DMF) in human. Poster presentation at the 4th International Symposium on Biological Monitoring in Occupational and Environmental Health, 1998.
Mráz J, Jheeta P, Gescher A, Hyland R, Thummel K, Threadgill M D. Metabolism of N,N-Dimethylformamide: Key to the understanding of its toxicity. Chem Res Toxicol 1993; 6:245-251.
Mraz J, Nohova H. Absorption, metabolism and elimination of N,N-dimethylformamide in humans. Int Arch Occup Environ Health. 1992;64:85-92.
Mraz J, Nohova H. Absorption, metabolism and elimination of N,N-dimethylformamide in humans. Int Arch Occup Environ Health. 1992; 64:85-92.
Mráz J, Nohová H. Percutaneous absorption of N,N-dimethylformamide in humans. Int Arch Occup Environ Health 1992; 64: 79-83.
Nomiyama T. Nakashima H. Chen LL. Tanaka S, et al. N,N-dimethylformamide: significance of dermal absorption and adjustment method for urinary N-methylformamide concentration as a biological exposure item. Int Arch Occup Environ Health 2001; 74:224-228.
Pirot F, Berardesca E, Kalia YN, Singh M, Maibach HI, Guy RH. Stratum corneum thickness and apparent water diffusivity: facile and noninvasive quantitation in vivo. Pharmaceutical Research 1998;15:492-4.
Rosenberg J, Rempel D. Biological monitoring. Occup Med 1990; 5: 491-8.
Rougier A, Dupuis D, Lotte C, Maibach HI. Stripping method for measuring percutaneous absorption in vivo. In: Brnaugh RL, Maibach HI, editors. Percutaneous absorption: drugs-cosmetics-mechanisms-methodolgoy. 3rd ed, New York: Marcel Dekker, Inc;1999. p. 375-94.
Schneider T, Cherrie JW, Vermeulen R, Kromhout H. Dermal exposure assessment. Annals of Occupational Hygiene. 2000;44:493-9.
Tomasini M. Todaro A. Piazzoni M. Peruzzo GF. Pathology caused by dimethylformamide: study of 14 cases. Medicina del Lavoro. 1983;74:217-20.
Tsai JC, Guy RH, Thornfeldt CR, Gao WN, Feingold KR, Elias PM. Metabolic approaches to enhance transdermal drug delivery. 1. Effect of lipid synthesis inhibitors. Journal of Pharmaceutical Sciences 1996; 85:643-8.
Walter D, Jochim C, Knecht U. Toxicolokinetic study on N,N-dimethylformamide for the re-evaluation of the Biological Tolerance alue (BAT) in Germany. In: Hallier E. Documentation from the 38th annual conference of the German Society of Occupational and Environmental Medicine, Wiesbaden, Germany, Rindt-Druck Fulda, p.619-20.
Wrbitzky R. Liver function in workers exposed to N,N-dimethylformamide during the production of synthetic textiles. Int Arch Occup Environ Health. 1999;72:19-25.
陳俊璋,聚尿樹脂及合成皮製造工廠勞工二甲基甲醯胺暴露研究,中國醫藥學院碩士論文,民國89年。